Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 90%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
13,750
Total Claims
$1.5M
Drug Cost
867
Beneficiaries
$1,683
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-11%
Opioid rate vs peers
2.0% vs 2.2% avg
+19%
Cost per patient vs peers
$1,683 vs $1,411 avg
+36%
Brand preference vs peers
14.5% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.0%
Opioid Rate
275
Opioid Claims
$1,960
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,972 claims · $1.2M
Generic: 11,656 claims · $288K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 145 | $129K |
| Empagliflozin | 153 | $128K |
| Dulaglutide | 83 | $92K |
| Dapagliflozin Propanediol | 102 | $85K |
| Insulin Degludec | 128 | $85K |
| Insulin Degludec | 84 | $79K |
| Semaglutide | 58 | $72K |
| Sitagliptin Phos/Metformin Hcl | 67 | $43K |
| Rivaroxaban | 45 | $43K |
| Mirabegron | 49 | $40K |
| Fluticasone/Umeclidin/Vilanter | 50 | $35K |
| Icosapent Ethyl | 71 | $28K |
| Sitagliptin Phos/Metformin Hcl | 30 | $26K |
| Sitagliptin Phosphate | 20 | $25K |
| Semaglutide | 21 | $20K |
Prescribing Profile
Patient Profile
73
Avg Age
52%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About